Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

EVR vs NMR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

NMR Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 9–1 Matrix Metrics)

NMR Overall Winner 6-Pillar Tally: EVR 3 – 3 NMR Matrix Metrics: EVR 1 – 9 NMR

As of Nov 17, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over Evercore Inc. (EVR) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). EVR carries a Unified Composite Score of 40.2/100 (SELL) at $291.47 (13.7x Forward P/E, 22.1% operating margin), whereas NMR carries 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About EVR vs NMR
EVR NYSE
Evercore Inc.
Investment Advice
$291.47
-0.23% 1D
Market Cap $11.3B
TTM Revenue $4.84B
Forward P/E 13.7x
Beta / 30D Vol 1.57β · 58% Vol
Unified Composite Score
40.2 / 100 SELL
Tech 36.0 Fund 47.0 Flow 65.0 Mom 46.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 54
RSI-14: 54.5 · SMA20: $285.31 · SMA50: $272.86
NMR NYSE Head-to-Head Winner
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$9.34
-1.74% 1D
Market Cap $28.3B
TTM Revenue $14.9B
Forward P/E 12.7x
Beta / 30D Vol 1.03β · 29% Vol
Unified Composite Score
44.5 / 100 HOLD
Tech 47.0 Fund 49.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.5 · SMA20: $9.40 · SMA50: $9.68

6-Pillar Scorecard Institutional Category Breakdown (EVR 3 – 3 NMR)

Columns: Metric · EVR · NMR
1. Valuation Multiples NMR
Forward P/E 13.7x 12.7x
Trailing P/E 16.2x 11.2x
PEG Ratio 1.19x 0.81x
EV / Revenue 2.3x 1.9x
2. Growth & Scale NMR
Revenue Growth (YoY) +12.4% +17.9%
Earnings Growth (YoY) +15.2% +13.6%
TTM Revenue (USD) $4.84B $14.9B
Market Cap $11.3B $28.3B
3. Profitability & Quality NMR
Gross Margin 93.7% 77.4%
Operating Margin 22.1% 25.1%
Net Profit Margin 15.7% 17.1%
Return on Equity (ROE) 38.0% 11.5%
4. Balance Sheet & Cash Flow EVR
Cash Generation (TTM) $1.73B N/A
Cash Flow Margin 35.7% N/A
Net Cash / Leverage $260M Net Cash $8.17 Book/Sh · 11.5% ROE
Dividend Yield 1.19% 3.34%
5. Options & Positioning EVR
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 53.8% (11th %ile) 30.7% (<1st %ile)
Put/Call OI Skew 16.83x (Put-Skewed) Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat EVR
OpEx & R&D Intensity 71.6% of Rev ($3.46B) 52.3% of Rev ($7.77B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Scale & Operating Efficiency Moat
Supply-Chain Role Capital Markets Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: EVR (1) vs NMR (9)
Institutional Metric EVR NMR Criterion Row Edge
Market Capitalization
Scale
$11.3B $28.3B Larger Scale NMR
Trailing P/E Ratio
Valuation
16.2x 11.2x Lower Multiple NMR
Forward P/E Ratio
Valuation
13.7x 12.7x Lower Multiple NMR
Revenue Growth (YoY)
Growth
+12.4% +17.9% Higher Growth NMR
Operating Margin (TTM)
Profitability
22.1% 25.1% Higher Margin NMR
Net Profit Margin
Profitability
15.7% 17.1% Higher Margin NMR
Return on Equity (ROE)
Capital Efficiency
38.0% 11.5% Higher ROE EVR
52-Week Range Position
Momentum
32% ($245–$389) 60% ($7–$11) Stronger Trend NMR
Beta / 30D Volatility
Risk Regime
1.57β · 58% Vol 1.03β · 29% Vol Lower Realized Risk NMR
Unified Institutional Score
Composite Signal
40.2 / 100 (SELL) 44.5 / 100 (HOLD) Higher Composite NMR
Trailing 12M Revenue (USD)
Operating Scale
$4.84B $14.9B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
93.7% 77.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.19x PEG · 2.3x EV/Rev 0.81x PEG · 1.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.73B ($260M Net Cash) N/A ($8.17 Book/Sh · 11.5% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon EVR +15.19 pp
EVR: +17.55% · NMR: +2.36%
3M Horizon NMR +0.48 pp
EVR: -2.32% · NMR: -1.84%
6M Horizon NMR +26.52 pp
EVR: -9.83% · NMR: +16.69%
1Y Horizon NMR +31.61 pp
EVR: -5.29% · NMR: +26.32%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EVR vs NMR. Trailing 12-month operating profitability (EVR 22.1% vs NMR 25.1%) and valuation multiples (EVR 13.7x vs NMR 12.7x Forward P/E) are benchmarked directly in Pillar 4 below.

EVR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$4.84B
Gross Margin93.7%
Op. Margin22.1%
ROE / Fwd P/E38.0% · 13.7x
NMR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$14.9B
Gross Margin77.4%
Op. Margin25.1%
ROE / Fwd P/E11.5% · 12.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
EVR CONSOLIDATION
148d in phase · OBV NEUTRAL
Current IV 53.8%
IV Percentile 11th %ile
Put/Call OI Skew 16.83x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact EVR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NMR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 30.7%
IV Percentile <1st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NMR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
EVR Moat Profile High-Margin Pricing Power Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $11.3B market capitalization and 22.1% operating margin.
OpEx & R&D Reinvestment 71.6% of Rev ($3.46B)
90D Engineering Disclosures 0 Published
NMR Moat Profile Scale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $28.3B market capitalization and 25.1% operating margin.
OpEx & R&D Reinvestment 52.3% of Rev ($7.77B)
90D Engineering Disclosures 0 Published

Investor FAQ EVR vs NMR Key Questions & Quantitative Answers

As of Nov 17, 2026, Nomura Holdings, Inc (NMR) is the stronger overall head-to-head candidate over Evercore Inc. (EVR) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). EVR carries a Unified Composite Score of 40.2/100 (SELL) at $291.47 (13.7x Forward P/E, 22.1% operating margin), whereas NMR carries 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin). Technically, EVR sits in a Neutral phase (RSI 54.5, CONSOLIDATION options structure) and NMR sits in a Neutral phase (RSI 45.5, UNCLASSIFIED options structure).

NMR leads the Growth & Scale pillar: EVR posts +12.4% YoY revenue growth and +15.2% YoY earnings growth on $4.84B TTM revenue (93.7% gross margin, 22.1% operating margin), compared with NMR at +17.9% YoY revenue growth and +13.6% YoY earnings growth on $14.9B TTM revenue (77.4% gross margin, 25.1% operating margin). On trailing 12-month operating scale, EVR generates $4.84B in USD-normalized revenue versus $14.9B for NMR. In operating R&D and SG&A reinvestment, EVR deploys 71.6% of Rev ($3.46B) (0 90-day corporate R&D disclosures) versus 52.3% of Rev ($7.77B) (0 disclosures) for NMR.

NMR screens cheaper on headline valuation multiples. EVR trades at 13.7x Forward P/E, 16.2x Trailing P/E, 1.19x PEG, and 2.3x EV/Revenue (35.7% FCF margin), whereas NMR trades at 12.7x Forward P/E, 11.2x Trailing P/E, 0.81x PEG, and 1.9x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EVR (38.0% ROE) versus NMR (11.5% ROE) capital efficiency.

In options market volatility and institutional positioning, EVR carries 53.8% implied volatility (11th %ile, Compressed (<25th %ile)), a 16.83x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (1.57β · 58% Vol realized risk). By comparison, NMR carries 30.7% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 29% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.